Healthcare provider profile · identity verified

Harry Yeates, MD

Family Practice · DESTIN, FL · NPI 1578561973

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	804	253
Rosuvastatin Calcium	Rosuvastatin Calcium	401	116
Amlodipine Besylate	Amlodipine Besylate	383	113
Levothyroxine Sodium	Levothyroxine Sodium	316	92
Lisinopril	Lisinopril	238	69
Losartan Potassium	Losartan Potassium	214	70
Hydrochlorothiazide	Hydrochlorothiazide	202	72
Metoprolol Succinate	Metoprolol Succinate	149	44
Omeprazole	Omeprazole	149	51
Gabapentin	Gabapentin	143	53
Tamsulosin Hcl	Tamsulosin Hcl	141	45
Metformin Hcl	Metformin Hcl	137	39
Albuterol Sulfate Hfa	Albuterol Sulfate	130	52
Ezetimibe	Ezetimibe	123	36
Eliquis	Apixaban	119	25
Trazodone Hcl	Trazodone Hcl	116	32
Allopurinol	Allopurinol	115	30
Ozempic	Semaglutide	114	18
Escitalopram Oxalate	Escitalopram Oxalate	107	33
Furosemide	Furosemide	100	28
Potassium Chloride	Potassium Chloride	96	35
Metoprolol Tartrate	Metoprolol Tartrate	91	28
Simvastatin	Simvastatin	89	26
Diclofenac Sodium	Diclofenac Sodium	83	39
Fluticasone Propionate	Fluticasone Propionate	73	29
Carvedilol	Carvedilol	72	26
Prednisone	Prednisone	71	54
Montelukast Sodium	Montelukast Sodium	70	21
Pantoprazole Sodium	Pantoprazole Sodium	68	26
Famotidine	Famotidine	67	31
Sertraline Hcl	Sertraline Hcl	63	21
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	62	18
Clopidogrel	Clopidogrel Bisulfate	60	17
Valacyclovir	Valacyclovir Hcl	60	26
Pravastatin Sodium	Pravastatin Sodium	57	19
Quetiapine Fumarate	Quetiapine Fumarate	57	22
Alendronate Sodium	Alendronate Sodium	56	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	53	18
Benazepril Hcl	Benazepril Hcl	51	17
Finasteride	Finasteride	50	14
Meloxicam	Meloxicam	49	20
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	46	11
Valsartan	Valsartan	45	13
Fluoxetine Hcl	Fluoxetine Hcl	40	16
Duloxetine Hcl	Duloxetine Hcl	39	12
Celecoxib	Celecoxib	38	12
Venlafaxine Hcl Er	Venlafaxine Hcl	38	suppressed
Bupropion Xl	Bupropion Hcl	36	13
Hydralazine Hcl	Hydralazine Hcl	36	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	36	11
Mounjaro	Tirzepatide	35	suppressed
Ramipril	Ramipril	35	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	35	11
Citalopram Hbr	Citalopram Hydrobromide	33	suppressed
Trulicity	Dulaglutide	33	suppressed
Clonazepam	Clonazepam	32	suppressed
Atenolol	Atenolol	31	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	31	26
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	31	suppressed
Methocarbamol	Methocarbamol	30	11
Sumatriptan Succinate	Sumatriptan Succinate	29	suppressed
Alprazolam	Alprazolam	28	suppressed
Glimepiride	Glimepiride	28	suppressed
Clobetasol Propionate	Clobetasol Propionate	27	suppressed
Liothyronine Sodium	Liothyronine Sodium	27	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	26	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Tizanidine Hcl	Tizanidine Hcl	26	15
Lorazepam	Lorazepam	25	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	24	suppressed
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Metformin Hcl Er	Metformin Hcl	24	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Estradiol	Estradiol	23	11
Pregabalin	Pregabalin	23	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Symbicort	Budesonide/Formoterol Fumarate	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Azelastine Hcl	Azelastine Hcl	21	11
Ibuprofen	Ibuprofen	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	19
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Jardiance	Empagliflozin	20	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	19	suppressed
Linzess	Linaclotide	19	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	19	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Amoxicillin	Amoxicillin	18	16
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	16
Ketoconazole	Ketoconazole	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	18	suppressed
Amiodarone Hcl	Amiodarone Hcl	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Mupirocin	Mupirocin	17	11
Buspirone Hcl	Buspirone Hcl	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Fluconazole	Fluconazole	16	11
Ibandronate Sodium	Ibandronate Sodium	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Telmisartan	Telmisartan	16	suppressed
Testosterone	Testosterone	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Cephalexin	Cephalexin	15	14
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	12
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Spironolactone	Spironolactone	14	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	13	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Diazepam	Diazepam	12	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	11	suppressed
Klor-Con 10	Potassium Chloride	11	suppressed
Metolazone	Metolazone	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error